Centralny Szpital Kliniczny Uck Wum

Warsaw 02-097

0 studies enrolling now · 2 studies all time

What they study most

CLL, Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL) — Running, not enrolling
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling